CD274 and neoplasm: For these patients with cold tumor or with enough inactivated T cell infiltration, boosting myeloid cell innate immunity to kill tumor cells followed by presentation of tumor specific antigen for T cell activation may enhance the anti-tumor activity for PD-1/PD-L1 blockades 29, 30.